Skip to main content
. 2015 Oct 23;142:481–487. doi: 10.1007/s00432-015-2055-6

Fig. 1.

Fig. 1

Progression free survival FIGO IIB-IV in months: PFS in 307 patients with FIGO IIB–IV ovarian cancer was 23.1 months (95 % CI 20.0–26.1 months)